Related Experiment Videos
A single center experience with extrahepatic cholangiocarcinomas
S R Johnson1, B S Kelly, L J Pennington
1Department of Surgery, Division of Transplantation, University of Cincinnati College of Medicine, Cincinnati, Ohio 45267-0558, USA.
Surgery
|October 17, 2001
Summary
Extrahepatic cholangiocarcinoma is a challenging diagnosis with limited curative options. Absence of a portal mass is key for potential curative resection and improved survival in these patients.
Area of Science:
- Hepatobiliary Surgery
- Surgical Oncology
- Gastroenterology
Background:
- Extrahepatic cholangiocarcinoma (ECC) is rare in Western populations.
- This study reviews 40 consecutive ECC cases treated at a single institution.
Purpose of the Study:
- To evaluate survival predictors in patients with extrahepatic cholangiocarcinoma.
- To assess the impact of surgical resection and tumor characteristics on patient outcomes.
Main Methods:
- Retrospective review of 40 patients diagnosed with ECC between 1992 and 2000.
- Kaplan-Meier method used to calculate survival rates.
- Analysis of tumor location, surgical approach, and presence of portal mass as prognostic factors.
Main Results:
- Tumors were predominantly located at the bifurcation (80%).
- Curative resection was achieved in 22.5% of patients, with a 5-year survival of 44.4%.
- Absence of a portal mass correlated with longer survival (28.4 months vs. 6.0 months).
Conclusions:
- Extrahepatic cholangiocarcinoma has a poor prognosis, with limited success rates for curative surgical resection.
- The absence of a portal mass is a significant predictor of successful curative resection and long-term survival.
- Further research into optimizing surgical strategies and adjuvant therapies for ECC is warranted.